HKPD Hong Kong Pharma Digital Ltd: רווח נקי למניה אחת בשנים עשר החודשים האחרונים

Hong Kong Pharma Digital is developing digital drug distribution in Asia, leveraging AI to identify available analogues. The annual net income per share TTM trend, as seen on the GURU.Markets chart, visualizes this progress, where 0.00 indicates the current level. High partner confidence is based on supply transparency, while management focuses on automation amidst a volatile regulatory environment.
HKPD (Hong Kong Pharma Digital): פילוחים אנליטיים ודוחות לפי אינדיקטורים

The business model of Hong Kong Pharma Digital (HKPD) is critically dependent on external logistics chains and wholesale suppliers. The trailing twelve months (TTM) earnings per share (EPS) dynamics are calculated as the ratio of the current total income over 12 months to the same period last year. By analyzing the relative EPS YoY TTM growth metric on GURU.Markets, an investor can discern the actual efficiency of cost management. This indicator reveals profit erosion resulting from operational dependence on outsourcing. A stable trend confirms the resilience of the company's capital.